Skip to main content
OpenTrials
Completed

NCT Number: NCT01234428

Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding

The purpose of this study is to determine whether esophageal dysmotility and dilatation is an important complication in the long term follow-up following laparoscopic gastric banding for morbid obesity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Surgery, Spital STS AG Thun

Thun, 3600, Switzerland

About this study

Using a yearly barium swallow the diameter of the esophagus will be monitored over the period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI more than 40

Exclusion criteria

  • BMI below 40

Treatment and study plan

Laparoscopic surgery

Procedure

Gastric banding

Gastric Banding

Procedure

laparoscopic gastric banding

Other names: morbid obesity

Primary outcomes

  1. esophageal dilatation

    Time frame: yearly follow-up over 12 year period

    esophageal dilatation or dysfunction

Sponsors and collaborators

Lead sponsor

Spital STS AG

Industry

Collaborators

  • Department of Medicine, Spital STS AG Thun

Registry information

Official study title

Esophageal Dysmotility Disorders Following Laparoscopic Gastric Banding - An Underestimated Complication.

Important dates

Study start
1998
Primary completion
2009
Study completion
2010
First posted
Nov 4, 2010
Registry last updated
Nov 4, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.